These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 37178414)

  • 21. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
    Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
    Front Genet; 2023; 14():1025163. PubMed ID: 36911389
    [No Abstract]   [Full Text] [Related]  

  • 24. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer.
    Ma S; Hao R; Lu YW; Wang HP; Hu J; Qi YX
    Breast Cancer (Dove Med Press); 2024; 16():199-219. PubMed ID: 38634039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of
    Zhang X; Shen L; Cai R; Yu X; Yang J; Wu X; Zhu Y; Liu X
    Front Cell Dev Biol; 2021; 9():686675. PubMed ID: 34277627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
    Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y
    Front Genet; 2020; 11():912. PubMed ID: 33193571
    [No Abstract]   [Full Text] [Related]  

  • 32. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
    Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
    J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
    Zhao X; Lin J
    Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
    Li L; Liu ZP
    J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.